Article
Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Jun 2011
Nazli Yunus, Colak Necmettin, Aksoy Omer N, Cakir Omer
Abstract excerpt
Thyroid vein thrombosis is a rare variety of venous thrombosis. The use of oral contraceptives and heterozygous methylenetetrahydrofolate reductase (MTHFR) gene mutation could have synergistic effects on the onset of venous thromboembolism. We report a 28-year-old woman with thyroid vein thrombosis. The thrombosis was possibly provoked by a combination of heterozygous MTHFR gene mutation and the use of a combined...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
